Alerts
DOJ and FDA Are Closely Monitoring the Marketing of COVID-19-Related Products
By Marissa Koblitz Kingman
Publications
Alerts
NJ Attorney General Launches Probe of Nursing Homes, Residential Care Facilities
By Matthew S. Adams and Marissa Koblitz Kingman
Alerts
SEC Sues Finance Firm for False Press Claims About COVID-19
By Marissa Koblitz Kingman
Alerts
May 14 Deadline Looms to Avoid Investigation of PPP Loans
By Marissa Koblitz Kingman
Alerts
Price Gouging Laws Triggered by States of Emergency Pose Risks for National and Local Retailers
By Marissa Koblitz Kingman and Joseph A. DeMaria
Alerts
New Jersey Is Actively Enforcing the Price Gouging Law During COVID-19 Emergency
By Marissa Koblitz Kingman
Articles
NJ Needs an AG Directive on Subpoenas Directed to Criminal Defense Attorneys
New Jersey Law Journal
By Matthew S. Adams and Marissa Koblitz Kingman
U.S. Supreme Court Limits States’ Civil Forfeiture Powers
By Matthew D. Lee and Marissa Koblitz Kingman
Alerts
The New IRS Voluntary Disclosure Regime: Worth the Price of Admission?
By Matthew D. Lee and Marissa Koblitz Kingman
Articles
NJ Needs Protections Against Compelled Disclosure of Mobile Device Passwords
New Jersey Law Journal
By Matthew S. Adams and Marissa K. Kingman
Articles
Appellate Division Tackles Second Twitter Case in Two Months
New Jersey Law Journal
By Matthew S. Adams and Marissa K. Kingman
2015 Retrospective on Meaningful Use, Healthcare Information Technology, and HIPAA
Garden State “FOCUS” (published by the New Jersey Chapter of the Healthcare Financial Management Association)
Page 2/ 2
